UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Inspire Medical Systems, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware
(State or incorporation or organization)

 

26-1377674
(IRS Employer Identification No.)

 

9700 63 rd  Ave. N., Suite 200
Maple Grove, Minnesota
(Address of Principal Executive Offices)

 

55369
(Zip Code)

 

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Name of each exchange on which

to be so registered

 

each class is to be registered

Common Stock, par value $0.001 per share

 

New York Stock Exchange

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.  x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.  o

 

Securities Act registration statement file number to which this form relates: 333-224176 .

 

Securities to be registered pursuant to Section 12(g) of the Act: None.

 

 

 


 

Item 1. Description of Registrant’s Securities to be Registered.

 

The description of the common stock, par value $0.001 per share, of Inspire Medical Systems, Inc. (the “Company”) as included under the caption “Description of Capital Stock” in the prospectus forming a part of the Company’s Registration Statement on Form S-1, originally filed with the Securities and Exchange Commission (the “Commission”) on April 6, 2018 (File No. 333-224176) and as subsequently amended (the “Registration Statement”), is hereby incorporated by reference herein. In addition, all of the above-referenced descriptions included in any prospectus relating to the Registration Statement filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.

 

Item 2. Exhibits.

 

Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Company are registered on The New York Stock Exchange and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

2


 

SIGNATURES

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Company has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: April 24, 2018

INSPIRE MEDICAL SYSTEMS, INC.

 

 

 

By:

/s/ Timothy P. Herbert

 

Name:

Timothy P. Herbert

 

Title:

Chief Executive Officer and President

 

3